NHC director Emil Hassan reports 7,500-share stock sale on Form 4

Rhea-AI Filing Summary

National HealthCare Corp (NHC) filed a Form 4 reporting that director Emil E. Hassan sold 7,500 shares of common stock on 11/25/2025 in an open market transaction coded “S.” The shares were sold at a price of $138.5164 per share.

After this sale, Hassan directly owns 65,595 NHC common shares. He also holds several stock option awards, each covering 7,500 shares of common stock, with exercise prices ranging from $55.75 to $96.03 and expiration dates between 05/05/2026 and 05/07/2030.

Insider Trade Summary

Net Seller: 7,500 shares

Net Sell 6 txns

Insider HASSAN EMIL E

Role Director

Sold 7,500 shs ($1.04M)

Type	Security	Shares	Price	Value
Sale	Shares of Common Stock	7,500	$138.5164	$1.04M
holding	Option to Purchase Common Stock [2021 Grant]	--	--	--
holding	Option to Purchase Common Stock [2022 Grant]	--	--	--
holding	Option to Purchase Common Stock [2023 Grant]	--	--	--
holding	Option to Purchase Common Stock [2024 Grant]	--	--	--
holding	Option to Purchase Common Stock [2025 Grant]	--	--	--

Holdings After Transaction: Shares of Common Stock — 65,595 shares (Direct); Option to Purchase Common Stock [2021 Grant] — 7,500 shares (Direct); Option to Purchase Common Stock [2022 Grant] — 7,500 shares (Direct); Option to Purchase Common Stock [2023 Grant] — 7,500 shares (Direct); Option to Purchase Common Stock [2024 Grant] — 7,500 shares (Direct); Option to Purchase Common Stock [2025 Grant] — 7,500 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/26/2025 - 04:02 PM Learn about SEC filing dates

FAQ

What insider transaction did NHC report on this Form 4?

The Form 4 reports that director Emil E. Hassan sold 7,500 shares of National HealthCare Corp common stock on 11/25/2025 in a transaction coded “S” (sale).

How many National HealthCare Corp (NHC) shares were sold and at what price?

Emil E. Hassan sold 7,500 shares of NHC common stock at a price of $138.5164 per share.

How many NHC shares does Emil E. Hassan own after the reported sale?

Following the reported transaction, Emil E. Hassan directly owns 65,595 shares of National HealthCare Corp common stock.

What is Emil E. Hassan’s relationship to National HealthCare Corp (NHC)?

Emil E. Hassan is reported as a director of National HealthCare Corp on this Form 4 filing.

What stock options on NHC does Emil E. Hassan hold according to this filing?

He holds several options to purchase 7,500 NHC common shares each, with exercise prices of $71.64, $69.19, $55.75, $96.03, and $94.66, and expiration dates from 05/05/2026 through 05/07/2030.

Does this Form 4 involve derivative securities for NHC?

Yes. The filing lists multiple stock options on NHC common stock, each covering 7,500 underlying shares, all held with direct ownership form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HASSAN EMIL E

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Shares of Common Stock	11/25/2025		S		7,500	D	$138.5164	65,595	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock [2021 Grant]	$71.64							05/06/2022	05/05/2026	Common Stock	7,500		7,500	D
Option to Purchase Common Stock [2022 Grant]	$69.19							05/05/2023	05/04/2027	Common Stock	7,500		7,500	D
Option to Purchase Common Stock [2023 Grant]	$55.75							05/04/2024	05/03/2028	Common Stock	7,500		7,500	D
Option to Purchase Common Stock [2024 Grant]	$96.03							05/09/2025	05/08/2029	Common Stock	7,500		7,500	D
Option to Purchase Common Stock [2025 Grant]	$94.66							05/08/2026	05/07/2030	Common Stock	7,500		7,500	D

Explanation of Responses:

	/s/ Emil E. Hassan	11/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.